| URL | https://pharmaceuticalmanufacturer.media/pharma-ma |
| Source | Pharmaceutical |
| Date Published | 10/17/2023 |
| Company/Division name | Sirio Pharma Co |
| Parent company | Sirio Pharma Co |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2023 |
| Year reshoring implemented or to be implemented: | 2023 |
| Country(ies) from which reshored: | China |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | gummy |
| What domestic positive factors made reshoring more attractive? | Under-utilized capacity |